EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cardiomyocyte proliferation and regeneration in congenital heart disease

Jialiang Liang, Xingyu He, Yigang Wang

Pediatric Discovery · 2024

DOI: 10.1002/pdi3.2501 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Discovery, 2024. Verfasst von Jialiang Liang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Heart Association-American Stroke Association, NHLBI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite advances in prenatal screening and a notable decrease in mortality rates, congenital heart disease (CHD) remains the most prevalent congenital disorder in newborns globally. Current therapeutic surgical approaches face challenges due to the significant rise in complications and disabilities. Emerging cardiac regenerative therapies offer promising adjuncts for CHD treatment. One novel avenue involves investigating methods to stimulate cardiomyocyte proliferation. However, the mechanism of altered cardiomyocyte proliferation in CHD is not fully understood, and there are few feasible approaches to stimulate cardiomyocyte cell cycling for optimal healing in CHD patients. In this review, we explore recent progress in understanding genetic and epigenetic mechanisms underlying defective cardiomyocyte proliferation in CHD from development through birth. Targeting cell cycle pathways shows promise for enhancing cardiomyocyte cytokinesis, division, and regeneration to repair heart defects. Advancements in human disease modeling techniques, clustered regularly interspaced short palindromic repeats ‐based genome and epigenome editing, and next‐generation sequencing technologies will expedite the exploration of abnormal machinery governing cardiomyocyte differentiation, proliferation, and maturation across diverse genetic backgrounds of CHD. Ongoing studies on screening drugs that regulate cell cycling are poised to translate this nascent technology of enhancing cardiomyocyte proliferation into a new therapeutic paradigm for CHD surgical interventions.

Schlagwörter

Stichwörter der Autor:innen

cardiomyocytescongenital heart diseaseproliferationregenerative medicine

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA.

Förderung

  • American Heart Association-American Stroke Association
  • NHLBI NIH HHS
  • National Institutes of Health
  • American Heart Association

Zitieren

APA

Liang, J., He, X., & Wang, Y. (2024). Cardiomyocyte proliferation and regeneration in congenital heart disease. Pediatric Discovery. https://doi.org/10.1002/pdi3.2501

Vancouver

Liang J, He X, Wang Y. Cardiomyocyte proliferation and regeneration in congenital heart disease. Pediatric Discovery. 2024. doi:10.1002/pdi3.2501

BibTeX
@article{Liang2024,
  author = {Liang, Jialiang and He, Xingyu and Wang, Yigang},
  title = {Cardiomyocyte proliferation and regeneration in congenital heart disease},
  journal = {Pediatric Discovery},
  year = {2024},
  doi = {10.1002/pdi3.2501}
}
Kostenlos starten →